Theragnosis is a new concept in next-generation medicine that combines simultaneous diagnosis and therapeutics. The goal of the Molecular Diagnosis Research Team is to discover novel protein biomarkers for diagnosis of diseases with a particular emphasis on proteomics and to develop molecular diagnostic tools. By integration of molecular imaging and nanomedicine with chemistry, drug delivery and cell biology as well as clinical medicine, we develope cancer theragnosis platform technologies which enable 1) Specified delivery of anticancer drugs, 2) Targeted visualization of cancer and 3) Molecular diagnosis for early detection of cancer and monitoring response to drug treatment assessment.

Click to show hide the background image